Invention Grant
- Patent Title: Fused pyrimidine compound or salt thereof
- Patent Title (中): 融合嘧啶化合物或其盐
-
Application No.: US14784239Application Date: 2014-08-11
-
Publication No.: US09580432B2Publication Date: 2017-02-28
- Inventor: Satoru Iguchi , Fumihito Hosoi , Takeshi Sagara
- Applicant: TAIHO PHARMACEUTICAL CO., LTD.
- Applicant Address: JP Chiyoda-ku
- Assignee: TAIHO PHARMACEUTICAL CO., LTD.
- Current Assignee: TAIHO PHARMACEUTICAL CO., LTD.
- Current Assignee Address: JP Chiyoda-ku
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2013-167600 20130812
- International Application: PCT/JP2014/071158 WO 20140811
- International Announcement: WO2015/022926 WO 20150219
- Main IPC: A01N43/90
- IPC: A01N43/90 ; A61K31/519 ; C07D487/00 ; C07D487/04 ; C07D519/00 ; C07F5/02
Abstract:
Provided is a novel compound having BTK inhibitory action and a cell proliferation suppressing effect. Also provided is a medicine useful for the prevention and/or treatment of a disease associated with BTK, particularly cancer, based on BTK inhibitory action. A compound represented by formula (I) [wherein R1 to R3, W, A, Y and Z respectively have the meanings as defined in the specification], or a salt thereof is disclosed.
Public/Granted literature
- US20160115168A1 NOVEL FUSED PYRIMIDINE COMPOUND OR SALT THEREOF Public/Granted day:2016-04-28
Information query
IPC分类:
